Cargando…
Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
OBJECTIVE: Quetiapine, an atypical second‐generation antipsychotic drug, is approved for treatment of schizophrenia, bipolar disorder, and depression. Due to the limitations of clinical trials, the association between quetiapine and rare cardiac adverse events (AEs) is still unclear. This study is t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401141/ https://www.ncbi.nlm.nih.gov/pubmed/37032639 http://dx.doi.org/10.1111/cns.14215 |